During Q4, ClearBridge International Growth EAFE Strategy underperformed its MSCI EAFE Index benchmark and MSCI EAFE Growth ...

When you think about materials used in medicine, you likely picture metals, plastics, or synthetic gels. Researchers at the ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference -- Participation underscores growing excitement around company's momentum and potential in precision oncology ...

About Recludix Recludix is a clinical-stage company with leading, innovative platform approaches to discover and develop potent and selective inhibitors of challenging protein targets. The company’s ...

But the bigger point is how foundational these stories are to how we narrate struggle and resilience. Middle school teaches ...

A succession of loud bangs and the sounds of a chainsaw and barking dogs filled the courtroom, punctuated by calls of “get ...

Jackery, a global leader in portable power and green energy solutions, today unveiled the Jackery Explorer 1500 Ultra, a ...

Lawmakers convened Jan. 13 for the formal address, which served as an outline of Gov. Rhoden's agenda for South Dakota's ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

Solar power is already one of the fastest growing sources of electricity on the planet, yet scientists say it is still only ...